Marketing Built for Blood Disorder and Haematology Clinics

Haematology Advertising Rules: Laboratory Claims, Prescription Medicines and Blood Cancer Pages

Most private haematology work is benign: anaemia, raised ferritin, low platelets, clotting problems and abnormal results found on a health screen. That makes laboratory accuracy central. If the clinic runs or commissions tests, say which laboratory processes them and whether it holds UKAS accreditation to the medical laboratory standard. Consultants should be on the GMC Specialist Register for haematology, and the British Society for Haematology publishes the guidelines most UK haematologists work to.

Iron infusions, anticoagulants and other treatments are prescription-only medicines, so they cannot be promoted to the public as products. A page can explain that the consultant may recommend iron replacement after assessment; it should not sell "iron drip packages". Where the clinic also sees blood cancers, those pages fall under the Cancer Act 1939, which restricts advertising offers to treat cancer, so take legal advice on how they are framed. CQC registration for treatment and diagnostic procedures is needed in England.

How Patients Search After an Abnormal Blood Test

Haematology searches are triggered by a number on a results sheet:

• "high ferritin what does it mean" and "haemochromatosis test"
• "low platelets causes" and "low white blood cell count"
• "iron deficiency anaemia specialist" and "iron infusion private"
• "blood clotting disorder test" and "DVT and family history"
• "private haematologist near me"

Each common abnormality deserves a results-explained page, written by the haematologist, that says when a result is likely to be harmless and when it needs prompt review.

What a Haematology Clinic Website Should Publish

Patients and GPs want to know what will happen with their results:

• Conditions seen, separated into anaemia and iron problems, clotting and bleeding disorders, and abnormal counts.
• Which tests can be done at the first visit, and which laboratory processes them.
• Whether existing results from a GP or screening company are reviewed before the appointment.
• Fees for consultation, tests and follow-up, and how insurer authorisation works.
• How the report and recommendations are returned to the GP.

GPs often want advice rather than a full referral, so some haematologists offer a written advice service on results, which can build relationships with practices.

Referral, Insurer and Self-Pay Routes Into Haematology

GPs refer when results are persistently abnormal and NHS waits are long. Private health screening companies are an underrated source: their customers receive unexpected results and need somewhere to go. A short page for screening providers and occupational health teams can bring a steady stream of appropriate patients.

Women with heavy periods and iron deficiency, pregnant women with clotting histories and people with a family history of thrombosis are distinct groups worth their own pages. Patients found to have a blood cancer are usually best served by an oncology and haematology service, and explaining that onward route builds confidence.

Insurers usually authorise a haematology consultation after a GP referral, but tests ordered before authorisation may not be covered. Explaining that sequence on the fees page saves awkward conversations later.